VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹215 Cr | ₹170 Cr | ₹142 Cr | ₹116 Cr | ₹75 Cr |
What is the latest Profit & Loss Account Balance ratio of VENUS REMEDIES ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹215 Cr |
| Mar2024 | ₹170 Cr |
| Mar2023 | ₹142 Cr |
| Mar2022 | ₹116 Cr |
| Mar2021 | ₹75 Cr |
How is Profit & Loss Account Balance of VENUS REMEDIES Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹215 Cr | 26.31 | |
| Mar2024 | ₹170 Cr | 19.91 | |
| Mar2023 | ₹142 Cr | 22.50 | |
| Mar2022 | ₹116 Cr | 54.58 | |
| Mar2021 | ₹75 Cr | - | |
Compare Profit & Loss Account Balance of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹865.6 Cr | 14.4% | 42.5% | 92.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,077.0 Cr | 2.8% | 6.3% | -1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,324.0 Cr | -2.1% | -2.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,235.0 Cr | -2.5% | 4.2% | 21.5% | Stock Analytics | |
| CIPLA | ₹123,294.0 Cr | 0% | -3.3% | 0.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,336.0 Cr | 1.3% | -0.5% | -0.2% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 14.4% |
42.5% |
92.7% |
| SENSEX | 0.9% |
2.1% |
8.3% |
You may also like the below Video Courses